LSE:OXB (Oxford BioMedica plc)
About OXB
Oxford BioMedica PLC is a player in the healthcare market in the United Kingdom. As a biopharmaceutical company, it focusses on the field of immunotherapy by managing a platform of technologies in designing gene-based medicines. The company operating segments include the Platform segment consists of the revenue-generating bioprocessing and process development activities undertaken for third parties. Its Product segment consists of the clinical and preclinical development of in vivo and ex vivo gene and cell therapy products. The company derives the maximum revenue from the Platform segment. Its Platform includes LentiVector, LentiStable, TRiPSystem, SecNuc, Analytics, and others. Geographically, it generates the majority of revenue from Europe.
Oxford BioMedica plc (LSE: OXB) Latest News

Page
Investing in Genetics: Top UK Genetics Stocks of 2023

Page
Investing in Biotech: Top UK Biotech Stocks of 2023
Investing Articles
1 FTSE 250 stock to buy for long-term growth

Investing Articles
1 UK stock I’d buy in 2022 to try to double my money
Investing Articles
The Oxford Biomedica share price is up 80% in a year. Here’s what I’d do

Investing Articles
The Oxford BioMedica share price surges on earnings
